Please find herewith the disclosures under Regulations 30 and Regulations 30A of the SEBI LODR - Public Announcement for Execution of Share Purchase Agreement.
BLISSGVS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Anupam Rasayan India Limited has entered into a Share Purchase Agreement to acquire 43.30% (4,58,03,024 shares) of Bliss GVS Pharma Ltd from multiple sellers, including 31.59% from promoter group members (Mr. Narsimha Shibroor Kamath, Dr. Vibha Gagan Sharma, Ms. Shruti Vishal Rao) and 11.70% from non-promoter shareholders. The deal is valued at ₹1,369.51 crore at ₹299 per share. The Purchaser also has options to acquire additional shares (up to 4.90% balance shares and retained shares within 12 months). The transaction will result in a change of control, making Anupam Rasayan the new promoter, with existing promoters exiting entirely. As required under SEBI SAST Regulations, the Purchaser will launch an open offer to public shareholders for up to 26% of the company.
This is a major control transfer transaction. The open offer at ₹299 per share may influence the stock price. Promoters are completely exiting, and a new entity (Anupam Rasayan) will take control, which typically triggers shareholder interest and price movement.